Adricin
Brand Name: ADRICIN
Composition: Epirubicin Injection IP
Form: Injection (For IV use only, Single-use Vial)
Manufacturer/Marketer: Adley
Product Description
Medical Info
ADRICIN is a prescription antineoplastic medication containing Epirubicin (50 mg/25 ml), a cytotoxic anthracycline antibiotic used in cancer chemotherapy. It functions by intercalating into DNA strands and inhibiting topoisomerase II, effectively halting the replication of rapidly dividing malignant cells. ADRICIN is a cornerstone treatment widely utilized in component regimens for breast cancer, gastric cancers, advanced ovarian cancer, and lymphomas. Due to the high risk of serious adverse effects—particularly cumulative cardiac toxicity and severe myelosuppression—this specialized therapy must be prepared and administered exclusively by qualified medical oncologists within a clinical hospital setting.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
